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 Aromatic foldamers containing 1,4,5,8-naphthalenetetracarboxylic diimide (NDI) and 
1,5-dialkoxynaphthalene (DAN) in alternation have been shown to assemble into supramolecular 
structures and, when heated, irreversibly aggregated fibrils.1–4 By replacing electron-rich DAN 
with similarly electron-rich aminoalkoxynaphthalene (AAN) in a similarly alternating peptide, 
we hypothesize that we can form similar stacked and fibril structures when the two monomers 
are connected by patterned charged and hydrophobic amino acids. Notably, AAN has a pKa of 
approximately 5, meaning pH can be used as a switch to alter the charge state of AAN, which we 
hypothesize can be used to alter the stacked or aggregated structure of the peptide as a whole. 
Presently, syntheses toward peptides with high fibril-forming propensities are being optimized, 
with the aim of studying their behaviors in response to pH modulation. In this work, we have 
also explored the π stacking and charge transfer behavior of an AAN- and NDI-containing 
peptide in both neutral and acidic environments.  
INTRODUCTION 
Aromatic foldamers based on repeating 1,4,5,8-naphthalenetetracarboxylic diimide (NDI) 
and 1,5-dialkoxynaphthalene (DAN) monomers have shown significant promise as self-
assembling supramolecular structures.1–3 These foldamers rely on noncovalent interactions 
between the electron-deficient NDI surface and electron-rich DAN surface, hydrogen bonding, 
and solvophobic effects to drive face-centered stacking when they are connected in an alternating 
fashion. Furthermore, there is a charge transfer interaction between NDI and DAN that also 
promotes intramolecular face-centered stacking. When heated, peptides containing NDI and 
DAN in alternation with patterned charged and hydrophobic amino acids have demonstrated an 
irreversible conversion from stacked foldamers to tightly intertwined 1D fibrils.4–6 This pattern 
of residues promote fibril formation as the hydrophobic side chains aggregate in the fibril core 
while the hydrophilic residues remain exposed. Additionally, these linkers provide adequate 
chain lengths to allow for proper face-centered stacking between the π surfaces.  
 
Figure 1. Chemical structures of NDI and DAN monomers. 
Figure 2. Proposed NDI-DAN fibril structure.4 
This class of aromatic foldamer adequately mimicked biological fibrils, but did so in an 
irreversible manner. Biological systems, however, are dynamic, responding to stimuli and 
adjusting their conformation, interaction, or activity accordingly. Thus, a more accurate 
biomimetic system ideally does just that. This can be achieved by replacing DAN with 1,5-
aminoalkoxynaphthalene (AAN), which, like DAN, has an electron-rich π system over pH ~5. 
However, under pH ~5, its secondary aniline is protonated, decreasing the electron density of the 
π system and interfering with the noncovalent interactions that contribute to AAN-NDI stacking. 
pH is an effective trigger for selective modulation of the higher-order structures that form as a 
result of interactions between NDI and AAN, increasing the dynamicity of the system. This 
offers insight into the noncovalent interactions that govern protein folding and allostery. When 
applied to higher-order structures such as 1D fibrils, the ability for one to drastically switch the 
electron density on AAN’s surface provides a more accurate mimic of biologically relevant 
fibrils in our abiotic system.   
 
Figure 3. Chemical structure of AAN monomer.  
The goal of this project is to take advantage of AAN’s ‘switchable’ nature in order to 
selectively modulate supramolecular structures in aqueous solution. First, this requires 
synthesizing NDI and AAN monomers suitable for peptide synthesis. Next, these monomers 
must be incorporated into a peptide similar to those that have previously been shown to form 
fibrils. From there, the noncovalent interactions between NDI and AAN in the fibril-forming 
peptide were investigated as they assembled into larger supramolecular structures. Based on 
previous studies with DAN-NDI peptides and the similarities between DAN and AAN, we 
expect the NDI-AAN peptide to fold such that NDI and AAN could stack in a face-centered 
manner. To this point, a working syntheses toward NDI and AAN monomers have been 
developed, and the solid phase peptide synthetic strategy is currently being optimized. 
Once the peptide was synthesized and purified, the project will shift toward exploring 
structural manipulation in response to stimuli. Iverson has proven that NDI-DAN foldamers will 
irreversibly assemble into 1D amyloid fibrils upon heating.4–6 We hypothesize that when heated, 
the NDI-AAN peptide will form fibrils, similar to the NDI-DAN peptide. This phase will begin 
immediately after an effective synthetic strategy toward fibril-forming peptides is developed. 
In this work, we intend to demonstrate how AAN’s ‘pH-switchable’ nature should allow 
for the formation of this specific fibril to be reversible, as the electronic interactions that hold its 
backbone together can be modulated by adjusting pH. That is, we aim to engineer a system in 
which broader conformational structure and properties can be predictably altered by using a pH 
‘switch.’ Presently, we have synthesized an AAN- and NDI-containing peptide (peptide 1A), but 
not one designed to have a propensity toward fibril formation. In UV/Visible spectroscopy 
studies with this peptide, we have observed an unexpected charge transfer between AAN and 
NDI at pH 1-2, when AAN is protonated, suggesting the two monomers may still be stacking in 
acidic buffer. Further UV/Vis experiments with AAN- and NDI- containing peptides will be 
conducted to further explore this low-pH charge transfer phenomenon, particularly how it 
pertains to fibril formation.  
METHODS  
NDI Synthesis 
1, 4, 5, 8-naphthalenetetracarboxylic dianhydride (2.00 g, 1 eq, 7.46 mmol) was 
suspended in isopropanol (80 mL). DIPEA (964 mg, 1.30 mL, 1 eq, 7.46 mmol) was added to the 
reaction mixture (Figure 4). tert-butyl (3-aminopropyl)carbamate (1.30 g, 1.30 mL, 1 eq, 7.46 
mmol), dissolved and diluted in isopropanol (120 mL), was added dropwise to the mixture via 
addition funnel over 2 hours. Once the entire tert-butyl (3-aminopropyl)carbamate solution was 
added to the reaction mixture, the reaction was allowed to stir under reflux for 20 minutes. 
Following the 20-minute reaction time, DIPEA (1.93 g, 2.60 mL, 2 eq, 14.9 mmol) were added 
to the reaction mixture, followed by beta-alanine tert-butylester hydrochloride (1.35 g, 1 eq, 7.46 
mmol). This reaction mixture was allowed to stir under reflux overnight. The resulting solution 
was then concentrated under reduced pressure. The solid intermediate was dissolved in DCM, 
then washed with 5% HCl, water (3x), and saturated brine solution. The organic layer was dried 




tetrahydrobenzo[lmn][3,8]phenanthrolin-2(1H)-yl)propanoate was then dissolved in DCM to 
give a 0.4 M solution (Figure 4). Excess TFA was slowly added to the reaction mixture via 
addition funnel. The resulting solution was allowed to stir at room temperature for 2 hours. The 
Boc-hydrolyzed product was concentrated under reduced pressure and rinsed with heptane, 
resulting in 3-(7-(3-aminopropyl)-1,3,6,8-tetraoxo-3,6,7,8-
tetrahydrobenzo[lmn][3,8]phenanthrolin-2(1H)-yl)propanoic acid, trifluoroacetate. This 
intermediate was carried forward to the final synthetic step without purification or quantification. 
3-(7-(3-aminopropyl)-1,3,6,8-tetraoxo-3,6,7,8-tetrahydrobenzo[lmn][3,8]phenanthrolin-
2(1H)-yl)propanoic acid, trifluoroacetate was suspended in a mixture of water (20 mL) and 
acetonitrile (20 mL). Potassium carbonate (3.1 g, 3 eq, 22 mmol) were added to the solution 
(Figure 4). Additional potassium carbonate was added until the remaining TFA was fully 
quenched. Separately, a 0.5 M solution of Fmoc succinamide (2.5 g, 1 eq, 7.5 mmol) in 
acetonitrile (15 mL) was prepared. The two solutions were combined and allowed to stir at room 
temperature for 4 hours. The final solution was diluted with 1M HCl, causing a solid to 
precipitate out of solution. The precipitate was filtered from the solution, rinsed with hexanes, 
and dried on the filter. Once dry, the precipitate was suspended in methanol and stirred for 30 
minutes. After 30 minutes, the remaining precipitate was filtered from the solution and dried on 
the filter, resulting in 3-(7-(3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)propyl)-1,3,6,8-
tetraoxo-3,6,7,8-tetrahydrobenzo[lmn][3,8]phenanthrolin-2(1H)-yl)propanoic acid, a yellow 
powder, in a 67% yield for the complete synthesis. NMR analysis confirmed the identity and 
purity of this compound (Figure 5).  
 
Figure 4. NDI Synthetic Scheme  
Figure 5. 1H NMR spectrum of NDI. 
AAN Synthesis 
Nitrogen gas was bubbled through EtOH (50 mL) in a flame-dried flask for 15 minutes. 
5-aminonaphthalen-1-ol (3.00 g, 1.00 eq, 18.85 mmol) was added, followed by the addition of 
boc-anhydride (4.113 g, 1.00 eq, 18.85 mmol) and guanidine hydrochloride (360.1 mg, 0.20 eq, 
3.77 mmol) (Figure 6). The reaction was allowed to react for 6 hours at room temperature. The 
resulting solution was concentrated under reduced pressure, and the dark purple product was 
dissolved in diethyl ether. The solution was washed with brine and filtered. The organic layer 
was then dried with sodium sulfate, concentrated under reduced pressure, and left on the high 
vac overnight to dry completely resulting in an 87% yield of tert-butyl (5-hydroxynaphthalen-1-
yl)carbamate (“Boc-AHN”), a dark purple solid. 
Triethylamine (3.46 g, 4.76 mL, 3.50 eq, 34.16 mmol) was added to a solution of 1-
Amino-2-bromoethane hydrobromide (2.00 g, 1.00 eq, 9.76 mmol) in DCM (85 mL) at room 
temperature and allowed to stir for 15 min. The solution was then cooled in an ice bath to 0 °C, 
and chloro(prop-2-en-1-yloxy)methanone (1.18 g, 1.037 mL, 1.00 eq, 9.76 mmol) dissolved in 
DCM (10 mL) was added dropwise. The reaction was allowed to stir at 0 °C for 2.5 hours, before 
being allowed to react at room temperature overnight. Water was added to the reaction, and the 
organic was separated. The organic layer was washed with 1M HCl and saturated brine solution, 
before being dried over sodium sulfate and concentrated under reduced pressure. This resulted in 
allyl (2-bromoethyl)carbamate, a peach colored liquid. 
Boc-AHN (1.84 g, 1.00 eq, 7.11 mmol), potassium carbonate (3.93 g, 4.00 eq, 28.5 
mmol), and potassium iodide (236 mg, 0.20 eq, 1.42 mmol) were added to a flame-dried flask. 
Allyl (2-bromoethyl)carbamate (1.48 g, 1.00 eq, 7.11 mmol) was dissolved in acetonitrile (55 
mL) and added to the reaction. The reaction was pump-purged with N2(g) and refluxed at 82 °C 
overnight. After cooling to room temperature, the reaction was washed with sodium bicarbonate 
and brine, and extracted into ethyl acetate. The remaining product in the aqueous layer was 
extracted into ethyl acetate twice. The organic layers were combined, dried over sodium sulfate, 
and concentrated under reduced pressure resulting in a dark purple crude product. To separate 
the remaining impurities, a normal phase silica column was run in hexanes/ethyl acetate. The 
column was run on a gradient from 100/0% hexanes/ethyl acetate to 0/100% hexanes/ethyl 
acetate. 
The collected fractions were concentrated and dissolved DCM (20 mL) and TFA (20 
mL), and allowed to stir at room temperature for 2 hours. The final reaction mixture was 
concentrated under reduced pressure. The resulting product was dissolved in acetonitrile (15 mL) 
without further purification. Potassium bicarbonate (2.85 g, 4.00 eq, 28.44 mmol) and potassium 
iodide (236 mg, 0.2 eq, 1.42 mmol) were added to the reaction mixture, followed by bromoacetic 
acid tert-butylester (4.16 g, 4.23 mL, 4.00 eq, 28.44 mmol). The reaction mixture was purged of 
O2 and allowed to mix under reflux overnight. The reaction was then poured directly into a 
separatory funnel and rinsed with ethyl acetate. It was then washed with sodium bicarbonate and 
brine. The aqueous layer was extracted into ethyl acetate. The organic layers were combined and 
dried over sodium sulfate, then concentrated on under reduced pressure. The wet solid product 
was dry loaded onto silica gel, and a normal phase silica column in hexanes/ethyl acetate was 
run. The column was run on a gradient from 100/0% hexanes/ethyl acetate to 0/100% 
hexanes/ethyl acetate, generating a 69% yield of tert-butyl (5-(2-
(((allyloxy)carbonyl)amino)ethoxy)naphthalen-1-yl)glycinate. 
A portion of tert-butyl (5-(2-(((allyloxy)carbonyl)amino)ethoxy)naphthalen-1-
yl)glycinate (1.18 g, 1.00 eq, 2.95 mmol) was dissolved in a mixture of TFA (15 mL) and DCM 
(mL) and allowed to stir at room temperature for 2 hours. The reaction was then concentrated 
under reduced pressure. The product, 5-(2-(((allyloxy)carbonyl)amino)ethoxy)-N-
(carboxymethyl)naphthalen-1-aminium trifluoracetate was precipitated out of solution by 
dissolving the resulting viscous liquid in minimal DCM, and then adding excess diethyl ether. 
The off-white solid product was filtered and dried, giving a 29% yield. 
 
Figure 6. AAN synthetic scheme. 
Figure 7. 1H NMR spectrum of AAN 
Solid-Phase Peptide Synthesis 
 Solid-phase peptide synthesis was conducted on low-loading (0.2 mmol/g) rink amide 
resin (0.5 g, 0.1 mmol) at room temperature. The resin was swelled in DCM for 30 minutes 
before being Fmoc-deprotected with 20% piperidine in DMF. The resin was then rinsed with 
DMF, methanol, and DCM. Each Fmoc-leucine and Fmoc-lysine (4 equivalents) was coupled 
with PyBOP and HOBt (4 equivalents each), and DIPEA (8 equivalents). These reactions were 
allowed to proceed for 1 hour before being rinsed with DMF, methanol, and DCM. Both lysine 
and leucine were coupled twice over with these parameters before moving onto the next residue 
in the sequence. Fmoc-NDI (4 equivalents) was coupled with PyBOP and HOBt (8 equivalents 
each), and DIPEA (16 equivalents). Alloc-AAN (2 equivalents) was coupled with PyBOP and 
HOBt (4 equivalents), and DIPEA (8 equivalents). Both NDI and AAN coupling reactions were 
allowed to proceed for approximately 16 hours. The high excess of coupling reagents and longer 
coupling time was necessary to ensure high-yielding coupling of the sterically hindered non-
canonical amino acids.  
  The final peptide was cleaved from resin as a C-terminal amide using a TFA cleavage 
cocktail (95:2.5:2.5 ratio of TFA to triisopropylsilane to water) for two hours. Following 
cleavage, crude peptide was purified on a reverse phase C18 column using a Biotage Isolera II. 
The column was run using a linear gradient from 95% solvent A (95% water, 4.9% acetonitrile, 
0.1% TFA) and 5% solvent B (4.9% water, 95% acetonitrile, 0.1% TFA) to 5% solvent A and 
95% solvent B. The product peak was identified using LCMS, and the associated fractions were 
collected and lyophilized. The calculated and observed m/z values were as follows: 
Peptide 1A (K-AAN-L-NDI-K-AAN-K, approximately 97% of product): Calculated for 
C72H95N15O13 (M+2H): m/z 688.86, found 688.5.  
 
Figure 8. Chemical structure of peptide 1A. 
Peptide 1B (K-AAN-L-NDI-K-AAN-L-NDI-K, approximately 3% of product): Calculated for 
C98H122N19O19 (M+3H): m/z 622.97, found 623.1.  
Figure 9. Chemical structure of peptide 1B. 
UV/Visible Spectroscopy 
UV/Vis samples were prepared in which approximately 10 mg of Peptide 1A was 
dissolved in 300 µL Milli-Q water to generate a stock solution. 40 µL of stock solution was 
dissolved in 40 µL of 0.173 M Na2HPO4/citric acid buffer at pH 6.99. A separate 40 µL aliquot 
of stock solution was dissolved in 40 µL of the same buffer, adjusted to pH 1-2 based on litmus 
paper. A third aliquot of 80 µL of stock solution was also collected for UV/Vis experiments in 
the absence of buffer. This sample exhibited a pH of approximately 1-2 based on litmus paper. 
These three samples were evaluated at a series of diluted concentrations to observe both the 
charge transfer absorbance peak at high concentrations and the AAN/NDI absorbance peaks at 




Iverson previously developed a synthetic strategy to generate NDI with a carboxylic acid 
extending from one imide and a 9-fluorenylmethyl chloroformate (Fmoc)-protected amine 
extending from the other.2 The resulting NDI amino acid was solid-phase peptide synthesis 
compatible and had orthogonal reactivity to side chain protecting groups (tertbutyloxy carbonyl, 
or “Boc”) and rink amide resin. Although successful, this synthetic scheme generated a statistical 
mixture of the desired unsymmetrical amino acid product and diamine/dicarboxylic acid 
byproducts (Figure 10). In order to address this concern, alter the additions to fit our purposes, 
and ensure NDI purity before beginning peptide synthesis, we modified the existing NDI 
synthesis. 
Figure 10. NDI synthetic scheme along with byproducts. 
Notably, in the first step of the synthesis, tert-butyl-(3-aminopropyl) carbamate was 
added dropwise over 2 hours to the reaction mixture while the system was under reflux. The 
slow addition promoted mono-addition of the Boc-protected diamine to the NDI precursor 
scaffold, thus pushing the reaction toward a 67% yield of the unsymmetrical product. This 
represents a significant improvement from previous syntheses toward NDI that generated a 
statistical mixture in which only approximately 41% of the product was unsymmetrical NDI.1 In 
step two, beta alanine tert-butylester hydrochloride was also added dropwise, again to promote 
mono addition to any starting material that had not yet reacted with the first amine. The Boc and 
tert-butyl ester hydrolysis occurred concomitantly in step three, before being Fmoc protected in 
the final step. 
While the altered synthetic strategy promoted more complete conversion of starting 
materials to the desired asymmetric NDI product, NMR analysis suggested that undesired 
symmetric diamine NDI was still present. These products were not easily differentiated with 
standard chromatographic methods, likely because of NDI’s large, hydrophobic surface and the 
covalently linked Fmoc protecting group. In an attempt to separate the two species, we found 
that the symmetric NDI byproduct is highly soluble in methanol, whereas our desired 
unsymmetric product was not. Using this difference in solubilities, we extracted the unwanted 
byproduct into methanol and dried the remaining insoluble portion on a filter. This allowed us to 
proceed to solid-phase peptide synthesis with pure NDI amino acid monomer, avoiding carrying 
a statistical mixture of products to peptide synthesis. 
AAN Synthesis  
The synthetic route to AAN monomer was developed by Hanne Henriksen (Figure 2) and 
repeated by me. Notably, the Fmoc protecting group strategy employed for NDI synthesis was 
ineffective with AAN, so allyloxycarbonyl (alloc), another solid-phase peptide synthesis 
orthogonal protecting group, was used to protect the otherwise reactive primary amine. 
Additionally, this protecting group system allowed AAN to remain soluble in DMF, which was 
essential for peptide synthesis. 
Figure 11. AAN synthetic scheme. 
Solid-Phase Peptide Synthesis  
Iverson previously demonstrated that both DAN and NDI can be effectively coupled onto 
rink amide resin with solid-phase support using a combination of PyBOP, HOBt, and N-
methylmorpholine (NMM) coupling reagents.5 To ensure a high-yielding synthesis, we 
employed a similar strategy with several notable adjustments. All peptides were synthesized on 
0.1 mmol of low-loading (0.2 mmol/g) rink amide resin. The lower loading volume mitigated 
some risk of stacking between the NDI and AAN residues during synthesis that would likely 
hinder subsequent residues from coupling onto the extending N-terminus.  
In order to address previous inefficiencies in NDI/AAN peptide synthesis, special 
considerations were made for all amino acid couplings. All of the canonical amino acids (present 
in 4x excess of rink amide resin) were “double coupled,” meaning they were allowed to couple 
in the presence of PyBOP/HOBt/DIPEA for one hour, were rinsed out of the solution, and 
allowed to couple again under the same conditions. AAN and NDI were also added in excess (2x 
and 4x versus rink amide, respectively), but due to starting material limitations, these residues 
were allowed to couple overnight instead of being double coupled. In these reactions, 4x and 8x 
excess of PyBOP and HOBt were used, respectively. Double couplings, extended reaction times, 
and excess coupling reagents proved effective in generating extended peptides that incorporated 
AAN and NDI, even with their additional steric bulk relative to canonical amino acids, which 
can be coupled in significantly less time. 
Although this route was largely successful in incorporating AAN and NDI into peptides, 
one step proved difficult, even under our bolstered coupling conditions. In both peptides 1A and 
1B, the common sequence, K-AAN-L-NDI-K-AAN, was effectively synthesized. However, in 
peptide 1B (target peptide) the final three residues on the N-terminus, leucine, NDI, and lysine, 
did not couple as intended. Based on LCMS data, only 3% of the peptide present in our product 
sample contained these three final residues. 97% of the product fractions consisted a peptide that 
omitted the final leucine and NDI (peptide 1A), generating the sequence K-AAN-L-NDI-K-
AAN-K. We believe that the ineffectiveness of this coupling step may have been the result of 
AAN-NDI stacking while tethered to solid support. This stacking would render the terminal 
AAN amine far less accessible to incoming activated carboxylic acids, particularly those that are 
sterically hindered by bulky side chains (leucine) or large π surfaces that have a high propensity 
to stack with the elongating peptide (NDI). Consequently, the only amino acid that was able to 
couple to the exposed AAN amine was lysine, the least sterically hindered of the three 
aforementioned residues, generating a pure sample of peptide 1A.  
Figure 12. Chemical structure of peptide 1A. 
Peptide 1A broke the alternating pattern of lysine (hydrophilic) and leucine 
(hydrophobic) residues intended to promote fibril formation upon heating. When unfolded, the 
linear sequence of peptide 1B would contain all lysine side chains on one side and all leucine 
side chains on the other. This would allow for the formation of a purely hydrophobic core and 
hydrophilic, charged exterior upon aggregation. However, due to the omission of leucine and 
NDI in the predominant peptide 1A, the probability of forming a purely hydrophobic core 
diminished. Instead, any structure that would form upon heating would include at least one 
charged lysine residue in its otherwise aliphatic core, decreasing the favorability associated with 
fibril formation. Future attempts to synthesize peptide 1B and form aggregates will involve 
incorporation of microwave irradiation and ethyl cyanohydroxyiminoacetate (Oxyma) during 
peptide synthesis to promote complete and high-yielding couplings. Once peptide 1B is 
effectively synthesized and purified, we can evaluate its fibril-forming and –disassembling 
tendencies in various heating and pH-modulating studies with CD, UV/Vis, and TEM.  
Spectroscopic Analysis 
 Although the major product of peptide synthesis, peptide 1A was not expected to form 
fibrils, it still offered insight into the stacking interactions between AAN and NDI. At pH 7, we 
expected AAN to stack in a face centered manner with NDI when the two are incorporated into a 
peptide with a sufficient 10-atom chain linking the two (as is the case in peptide 1A). This 
stacking interaction is driven by a combination of hydrophobic interactions that tends to 
maximize overlap of aromatic structures, favorable electrostatic interactions between the 
electron-rich π surface of AAN and electron-poor π surface of NDI, and charge transfer between 
the two residues. While the former two factors were well-defined in our system, the third 
remained somewhat ambiguous. Iverson demonstrated a charge transfer interaction between 
DAN and NDI in which the electron-rich DAN donated a short-lived radical to electron-poor 
NDI, forming a charge transfer complex in which DAN and NDI briefly maintained opposite 
charges.4 In this instance, the charge transfer likely stabilized the face-centered stacking 
interaction, and was visible as a wide peak at approximately 531 nm on the UV/Vis spectrum. 
 Given the electronic and structural similarities between AAN and DAN, we expected to 
observe a similar charge transfer absorbance peak in our spectroscopic analysis of peptide 1A. 
Notably, AAN’s increased electron density relative to DAN raised its HOMO closer to the 
LUMO of NDI, decreasing the energy gap to be bridged by charge transfer from a calculated 
5.24 eV in DAN/NDI to 4.98 eV in AAN/NDI. As such, we expected to see a similar charge 
transfer absorbance peak in the UV/Vis spectrum of peptide 1A when the peptide is in a face-
centered stack at pH 7. At the stock concentration and each subsequent dilution, only a minimal 
charge transfer absorbance peak was present. These data suggest that while there might have 
been face-centered stacking between AAN and NDI, it was likely not the peptide’s predominant 
conformation, resulting in a minimized absorbance signal. It is also possible that the charge 
transfer absorbance peak was diminished at pH 7 because the peptide took on a different 
conformation than simply a face-centered stack.7 In either case, CD analysis demonstrated 
notable exciton coupling, suggesting the π systems of the two monomers are interacting in 
solution at neutral pH. This phenomenon will be further explored and the presence or absence of 
a charge transfer between AAN and NDI will be verified in systems in which the donor to 
acceptor ratio is 1:1 and the peptide is fully dissolved in buffer.  
 
Figure 13. Electrostatic potential maps of NDI, DAN, AAN, and AAN+ monomers.  
 At low pH, we expected AAN’s secondary amine to be protonated, generating a cation 
that pulls a significant amount of electron density from the π surface. The resulting species, 
AANH+, should therefore have an unfavorable electrostatic interaction with electron-poor NDI, 
resulting in an unfolded peptide chain. Without this stacking interaction between AANH+ and 
NDI, the charge transfer between the two cannot occur. Contrary to this expectation, we 
observed a significant absorbance peak centered around approximately λ=600 nm when peptide 
1A was dissolved in pH 1-2 buffer, as well as in acidic water (due to the TFA salts present in the 
sample). We hypothesize that this peak represents a charge transfer from NDI, acting as a radical 
donor, to AANH+, acting as a radical acceptor due to its cationic, electron-deficient state. 
Although the AANH+/NDI calculated HOMO-LUMO gap (5.70 eV) is slightly larger than that 
of AAN/NDI, the comparable order of magnitude suggests that such a charge transfer is possible. 
Additionally, this behavior at pH 1 suggests that AANH+ and NDI are in close enough proximity 
to engage in charge transfer, meaning they are likely still stacked.  
 
Figure 14. Visible spectra of concentrated peptide 1A at varied pH in 0.087 M sodium 











































Figure 15. UV spectra of concentrated peptide 1A at varied pH in 0.087 M sodium 
phosphate/citric acid buffer. Spectra chosen based on similar absorbance values at 230 nm. 
 
Figure 16. CD spectrum of peptide 1A in citric acid/sodium phosphate buffer at pH 7. 
 
CONCLUSION 
Building on established synthetic strategies for NDI and AAN, as well as their 
incorporation into peptides, we were able to effectively synthesize a peptide containing both 
aforementioned non-canonical amino acids with canonical linkers. Although the major product 
was not one we had intended, it still offered us significant insight into the behavior of AAN and 
NDI monomers in peptide synthesis. In the future, this synthetic strategy will be adapted and 
improved to promote high-yielding, highly pure peptides even in extended sequences.  
The major product of this peptide synthesis, peptide 1A, also offered insight into the 


















adds some nuance to our understanding of this foldamer system. AAN and NDI are not just 
oppositely charged π surfaces and stack as such. Instead, the electronics of the π systems are 
responsive to their local environments, allowing the whole peptide to conform to its most 
energetically favorable state depending on pH. Future experiments will be conducted to study 
these stacking interactions as well as the impact of AAN’s protonation state and linker length on 
the allostery, electronics, and structure of the larger system. 
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